You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tracon

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

Lung Cancer Trial in Birmingham (TRC105)

Completed
  • Lung Cancer
  • Birmingham, Alabama
    UAB Comprehensive Cancer Center
Jun 24, 2021

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

Solid Tumor, Metastatic Cancer Trial in United States (TJ004309, Atezolizumab)

Active, not recruiting
  • Solid Tumor
  • Metastatic Cancer
  • Birmingham, Alabama
  • +3 more
Mar 31, 2022

Solid Tumors Trial in Santa Monica (TRC105, Bevacizumab, Axitinib)

No longer available
  • Solid Tumors
  • Santa Monica, California
    UCLA
Jan 28, 2021

NSCLC Trial in Birmingham, Tampa (Carotuximab (TRC105), OPDIVO)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +1 more
Jun 11, 2020

Hepatocellular Carcinoma Trial in Birmingham, Cleveland, Houston (Carotuximab (TRC105), Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Birmingham, Alabama
  • +2 more
Jul 2, 2020

Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • Adenocarcinoma, Prostate
  • Birmingham, Alabama
  • +4 more
Mar 29, 2021

Advanced Soft Tissue Sarcoma Trial in United States (TRC105 and Pazopanib)

Completed
Has Results
  • Advanced Soft Tissue Sarcoma
  • TRC105 and Pazopanib
  • Birmingham, Alabama
  • +8 more
May 11, 2020

Advanced Angiosarcoma Trial in Worldwide (TRC105, Votrient)

Completed
Has Results
  • Advanced Angiosarcoma
  • Tucson, Arizona
  • +38 more
May 11, 2020

Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor Trial in Boston, Columbus, Dallas

Terminated
Has Results
  • Gestational Trophoblastic Neoplasia
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jul 9, 2019

Choriocarcinoma Trial in Boston (TRC105, Bevacizumab)

Completed
Has Results
  • Choriocarcinoma
  • TRC105
  • Bevacizumab
  • Boston, Massachusetts
    Dana-Farber Cancer Insititue
May 17, 2019

Metastatic Breast Cancer Trial in Birmingham, Buffalo (TRC105, Capecitabine)

Completed
Has Results
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +1 more
Feb 28, 2019

Glioblastoma, Glioblastoma Multiforme Trial in Cincinnati, Cleveland, Columbus (TRC105, Bevacizumab)

Completed
Has Results
  • Glioblastoma
  • Glioblastoma Multiforme
  • Cincinnati, Ohio
  • +3 more
May 21, 2019

Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Birmingham, Alabama
  • +38 more
Oct 15, 2020

Adult Solid Tumor Trial in United States (TRC105 and Bevacizumab)

Completed
Has Results
  • Adult Solid Tumor
  • TRC105 and Bevacizumab
  • Birmingham, Alabama
  • +3 more
Nov 7, 2018

Non Small Cell Lung Cancer Trial (TRC105)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 4, 2019

Cancer, Tumor Metastasis Trial in United States (TRC105 chimeric anti-CD105 antibody)

Completed
  • Cancer
  • Neoplasm Metastasis
  • TRC105 chimeric anti-CD105 antibody
  • Scottsdale, Arizona
  • +3 more
Mar 2, 2012

Tumor Trial in Scottsdale, Santa Monica, Cleveland (TRC102 + pemetrexed)

Completed
  • Neoplasm
  • TRC102 + pemetrexed
  • Scottsdale, Arizona
  • +2 more
Sep 8, 2010

Cancer, Tumor Metastasis Trial in Birmingham, Phoenix, Santa Monica (TRC093 recombinant humanized IgG1k mAb)

Completed
  • Cancer
  • Neoplasm Metastasis
  • TRC093 recombinant humanized IgG1k monoclonal antibody
  • Birmingham, Alabama
  • +2 more
Feb 3, 2010